Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

17.10
-0.6700-3.77%
Post-market: 17.550.4500+2.63%19:30 EDT
Volume:1.40M
Turnover:24.25M
Market Cap:1.99B
PE:-13.07
High:17.83
Open:17.75
Low:17.01
Close:17.77
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.81
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.89
PE(LYR):-13.99

Loading ...

Should NovoCure’s (NVCR) Upgraded Momentum Score and Earnings Revisions Require Action From Investors?

Simply Wall St.
·
Yesterday

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

Simply Wall St.
·
Aug 11

NovoCure (NVCR) Stock Looks Undervalued With Shares Down 90% Over Five Years

Simply Wall St.
·
Jul 30

NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding

Benzinga Earnings
·
Jul 24

Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating

MT Newswires Live
·
Jul 24

Novocure price target raised to $20 from $18 at Wedbush

TIPRANKS
·
Jul 24

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey
·
Jul 24

Novocure is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 24

Novocure price target raised to $52 from $46 at H.C. Wainwright

TIPRANKS
·
Jul 24

Novocure Shares Rise After Co Boosts FY26 Revenue Guidance

Dow Jones
·
Jul 23

Novocure Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

Utah Medical Q2 Revenue Falls 14% on Lost Customers

Reuters
·
Jul 23

NovoCure's Q2 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Raised

MT Newswires Live
·
Jul 23

Novocure Q2 Revenue Beats, Lifts 2026 Outlook

Reuters
·
Jul 23

Novocure Q2 Revenue USD 183.584 Million Vs. IBES Estimate USD 172.4 Million

Reuters
·
Jul 23

GUIDANCE: (NVCR) NovoCure Expects Full Year 2026 Revenue Range $710M - $725M, vs. FactSet Est of $708.7M

MT Newswires Live
·
Jul 23

Earnings Flash (NVCR) NovoCure Posts Q2 Loss $0.13 per Share, vs. FactSet Est of $0.33 Loss

MT Newswires Live
·
Jul 23

NovoCure Q2 EPS $(0.13) Beats $(0.33) Estimate, Sales $183.584M Beat $172.437M Estimate

Benzinga Earnings
·
Jul 23

Novocure Q2 FY26 Net Loss Narrows to USD 15.66 Million; Revenue Rises 16% to USD 183.58 Million

Reuters
·
Jul 23

Novocure Q2 EPS USD -0.13

THOMSON REUTERS
·
Jul 23